What makes walking so great for your health and what else you need to do - The Seattle Times

Health experts say walking is an easy way to improve physical and mental health, bolster fitness and prevent disease.

Dr. Oz recommends adopting a brain-loving lifestyle - NJ.com

I’m approaching my 50th birthday and freaking out a little. I don’t want to face old age with declining cognition. Is it inevitable?

Doctors told me I wasn't old enough for cancer. When I finally got a diagnosis, it was Stage 4. - Business Insider

In this excerpt from "Too Young for Cancer," Katie Coleman describes receiving her cancer diagnosis after years of having her symptoms misdiagnosed.

‘My mom never talked about this.’ Menopause care is the hottest new workplace benefit - The Boston Globe

From support groups to nutritionists and sex coaches, companies are adding perks to help midlife women manage their symptoms.

Study Links Stress Hormones to Diabetes - Neuroscience News

New research suggests that stress hormones, rather than impaired insulin signaling, may primarily drive diabetes in obesity.

Turmeric and Green Tea: The Health Supplements Sending Americans to the ER - Indian Defence Review

The increasing popularity of herbal and dietary supplements has led to an alarming trend : a rise in hospitalizations due to their misuse. Recent research from the University of Michigan, Ann Arbor, has shed light on the potential dangers associated with comm…

Adults Learn Skills Faster, but Kids Retain Them Better With Sleep - Neuroscience News

Contrary to common beliefs, adults can learn new motor skills faster than children, but children retain these skills better due to more effective sleep-driven memory consolidation.

Prostate Cancer Overtreatment Common in Older Men - Newsmax

Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new study reports. Procedures like radiation therapy and prostate surgery are being employed more often in these men, causing side effects like incon…

New NYU Study May Teach Us New Pshat in a Pasuk - VINNews

by Rabbi Yair Hoffman Join our WhatsApp group Subscribe to our Daily Roundup Email An article in Nature Communications by an NYU team may teach a new pshat in a pasuk in Sefer Yirmiyahu.  In Yirmiyahu 17:10 the pasuk states: “I, Hashem, search the heart and e…

Fatty Liver Disease Now Affects 4 in 10 US Adults - Newsmax

Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns. By 2018, federal data showed that 42% of adults had some form of fatty liver disease -- higher than prior estimates, according to a t…

Why could Ozempic play a role in reducing the risk of Alzheimer's disease? - KHOU.com

New research suggests patients with Type 2 diabetes lowered their Alzheimer's risk with semaglutide

The #1 Drink to Limit to Reduce Dementia Risk, According to Dietitians - EatingWell

Nutrition experts share the latest research surrounding alcohol and dementia, offering advice on how to balance your beverages to promote brain health.

GNR 11-13-24: Progress Even in Trying Times - Daily Kos

Good morning, gnusies! Allow me to offer my usual apolitical (at least in terms of US politics) palate cleanser.

Strange Symptoms Appearing All Over the World: What Do We Really Know About Havana Syndrome? - The Daily Galaxy --Great Discoveries Channel

The Havana syndrome has puzzled experts and government officials since its first reported cases in 2016. This mysterious ailment, characterized by a range of unusual symptoms, has affected numerous U.S. diplomats and government employees worldwide. Despite ex…

Fatty Liver Disease Now Affects 4 in 10 U.S. Adults - HealthDay

WEDNESDAY, Nov. 13, 2024 (HealthDay News) -- Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new resea

'No Hint of Benefit' in Large Colchicine Trial - Medscape

There was no meaningful protection from major cardiac events after MI, reported investigators of the multinational placebo-controlled trial that is challenging common clinical practice.